Vanguard Group Inc Apellis Pharmaceuticals, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding APLS
# of Institutions
296Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$236 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$235 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$229 Million20.45% of portfolio
-
Morgan Stanley New York, NY9.63MShares$185 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$111 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.11B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...